203 related articles for article (PubMed ID: 31652393)
1. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
2. Identification of the two KIT isoforms and their expression status in canine hemangiosarcomas.
Chen YC; Liao JW; Hsu WL; Chang SC
BMC Vet Res; 2016 Jul; 12(1):142. PubMed ID: 27422008
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
4. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis.
Hussain S; Saxena S; Shrivastava S; Mohanty AK; Kumar S; Singh RJ; Kumar A; Wani SA; Gandham RK; Kumar N; Sharma AK; Tiwari AK; Singh RK
PLoS One; 2018; 13(12):e0208656. PubMed ID: 30517191
[TBL] [Abstract][Full Text] [Related]
8. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
[TBL] [Abstract][Full Text] [Related]
9. Expression of Oxytocin Receptors in Canine Mammary Tumours.
Benavente MA; Bianchi CP; Aba MA
J Comp Pathol; 2019 Jul; 170():26-33. PubMed ID: 31375156
[TBL] [Abstract][Full Text] [Related]
10. Advancing canine mammary tumor diagnostics: Unraveling the diagnostic potential of Cytokeratin 19 through droplet digital PCR analysis.
Tanvetthayanont P; Yata T; Boonnil J; Temisak S; Ponglowhapan S
Theriogenology; 2024 Mar; 217():127-135. PubMed ID: 38271766
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase expression analyses in canine mammary gland tumours - A pilot study.
Koltai Z; Szabó B; Jakus J; Vajdovich P
Acta Vet Hung; 2018 Jun; 66(2):294-308. PubMed ID: 29958529
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):175-83. PubMed ID: 24231306
[TBL] [Abstract][Full Text] [Related]
13. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
15. CD204-Expressing Tumor-Associated Macrophages Are Associated With Malignant, High-Grade, and Hormone Receptor-Negative Canine Mammary Gland Tumors.
Seung BJ; Lim HY; Shin JI; Kim HW; Cho SH; Kim SH; Sur JH
Vet Pathol; 2018 May; 55(3):417-424. PubMed ID: 29343199
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: An immunohistochemical and prognostic study.
Dolka I; Król M; Sapierzyński R
Res Vet Sci; 2016 Apr; 105():124-33. PubMed ID: 27033920
[TBL] [Abstract][Full Text] [Related]
18. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
19. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.
Kubo K; Matsuyama S; Katayama K; Tsutsumi C; Yonezawa K; Shimada T; Kotani T; Sakuma S; Ohashi F; Takamori Y
J Vet Med Sci; 1998 Dec; 60(12):1335-40. PubMed ID: 9879535
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]